Institutional Manager · CIK 0001425738
Redmile Group, LLC
San Francisco, CA · File #028-12776
Latest AUM
$1.36B
Positions
34
Top-10 Concentration
77.8%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | ZYMEWORKS INC | ZYME | -3,214,096 | -$84.6M | +$34.3M |
| ADD | NURIX THERAPEUTICS INC | NRIX | +4,415,514 | +$83.8M | +$35.8M |
| ADD | SCHOLAR ROCK HLDG CORP | SRRK | +1,316,390 | +$58.0M | +$26.6M |
| REDUCE | LIVANOVA PLC | LIVN | -808,745 | -$49.8M | +$8.5M |
| EXITED | AKERO THERAPEUTICS INC | 00973Y108 | -747,818 | -$35.5M | $0 |
| REDUCE | COGENT BIOSCIENCES INC | COGT | -771,200 | -$27.4M | +$46.7M |
| EXITED | 89BIO INC | 282559103 | -1,473,136 | -$21.7M | $0 |
| ADD | ANNEXON INC | ANNX | +3,750,000 | +$18.8M | +$12.4M |
| ADD | IMMUNOME INC | IMNM | +695,000 | +$14.9M | +$49.1M |
| ADD | RAPT THERAPEUTICS INC | 75382E208 | +333,333 | +$11.3M | +$4.5M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202534 pos · $1.36B
- 13F HOLDINGS REPORTQ/E Sep 202540 pos · $1.03B
- 13F HOLDINGS REPORTQ/E Jun 202548 pos · $939.6M
- 13F HOLDINGS REPORTQ/E Mar 202556 pos · $1.06B
- 13F HOLDINGS REPORTQ/E Dec 202462 pos · $1.43B
- 13F HOLDINGS REPORTQ/E Sep 202463 pos · $1.70B
- 13F HOLDINGS REPORTQ/E Jun 202463 pos · $1.65B
- 13F HOLDINGS REPORTQ/E Mar 202477 pos · $2.72B
- 13F HOLDINGS REPORTQ/E Dec 202368 pos · $2.10B
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | SCHOLAR ROCK HLDG CORP | SRRK | 5,220,846 | $230.0M | 16.94% |
| 2 | KRYSTAL BIOTECH INC | KRYS | 677,705 | $167.1M | 12.30% |
| 3 | NURIX THERAPEUTICS INC | NRIX | 8,093,908 | $153.5M | 11.31% |
| 4 | STOKE THERAPEUTICS INC | STOK | 4,034,070 | $128.0M | 9.43% |
| 5 | IMMUNOME INC | IMNM | 5,718,385 | $122.8M | 9.05% |
| 6 | REGENXBIO INC | RGNX | 4,368,804 | $62.9M | 4.63% |
| 7 | ADC THERAPEUTICS SA | ADCT | 15,666,731 | $55.3M | 4.07% |
| 8 | COGENT BIOSCIENCES INC | COGT | 1,437,918 | $51.1M | 3.76% |
| 9 | ANNEXON INC | ANNX | 10,050,644 | $50.5M | 3.72% |
| 10 | BEAM THERAPEUTICS INC | BEAM | 1,285,859 | $35.6M | 2.62% |
| 11 | NEUROGENE INC | NGNE | 1,459,599 | $30.1M | 2.21% |
| 12 | RAPT THERAPEUTICS INC | 75382E208 | 885,927 | $30.0M | 2.21% |
| 13 | ABSCI CORPORATION | ABSI | 8,253,316 | $28.8M | 2.12% |
| 14 | NUVATION BIO INC | NUVB | 3,163,256 | $28.3M | 2.09% |
| 15 | IDEAYA BIOSCIENCES INC | IDYA | 742,017 | $25.7M | 1.89% |
| 16 | SHATTUCK LABS INC | STTK | 5,539,724 | $20.2M | 1.49% |
| 17 | SILENCE THERAPEUTICS PLC | SLNCF | 2,164,777 | $13.2M | 0.97% |
| 18 | ZYMEWORKS INC | ZYME | 491,654 | $12.9M | 0.95% |
| 19 | FATE THERAPEUTICS INC | FATE | 12,872,946 | $12.6M | 0.93% |
| 20 | REPLIMUNE GROUP INC | REPL | 1,099,756 | $10.7M | 0.79% |